FILE PHOTO: Vials with a sticker reading, COVID-19 / Coronavirus vaccine / Injection only and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo
(Reuters) - Johnson & Johnson said its single-dose vaccine was 72% effective in preventing COVID-19 in the United States but a lower rate of 66% was observed globally in the large trial conducted across three continents and against multiple variants.
In the trial of nearly 44,000 volunteers, the level of protection against moderate and severe COVID-19 was just 57% in South Africa, where a particularly worrying variant of the novel coronavirus is circulating.
INSTANT VIEW-J&J COVID-19 vaccine is 66% effective trust.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from trust.org Daily Mail and Mail on Sunday newspapers.
A group of about 94,000 people living and working in group homes, shelters and correctional facilities is next up for COVID-19 vaccinations in Massachusetts.
The coronavirus vaccine rollout in Massachusetts moves into the next step of Phase 1 on Monday. The next group includes congregate care settings like group homes, shelters and corrections facilities. “They are deserving of health care,” said jail doctor Alysse Wurcel. “Treating these people who are in jail and preventing COVID in them is going to benefit everyone.” Wurcel is.
COVID-19 : New strain of COVID-19 detected in the United Kingdom could already be in the US – explica.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from explica.co Daily Mail and Mail on Sunday newspapers.